国际麻醉学与复苏杂志
國際痳醉學與複囌雜誌
국제마취학여복소잡지
International Journal of Anesthesiology and Resuscitation
2015年
9期
769-774,789
,共7页
麻醉药%心脑保护%临床研究
痳醉藥%心腦保護%臨床研究
마취약%심뇌보호%림상연구
Anesthetic%Cardio-neuroprotection%Clinical trials
麻醉药的心脑保护作用一直广受关注,但仍存在一些争议.尽管多数临床前研究发现常用麻醉药能减轻缺血/缺氧性心脑损伤,但临床研究却未得到确定性结论.综述近年来关于麻醉药心脑保护作用的临床研究,尤其是随机对照研究,结果表明,多数常用的麻醉药(吸入性麻醉药异氟醚、七氟醚,静脉麻醉药丙泊酚、右美托咪定等)均表现出一定的心脏保护作用,其中氟烷类吸入性麻醉药较静脉麻醉药效果更明显,可显著减轻心脏手术患者的心肌损伤.静脉麻醉药中,右美托咪定对心脏手术患者的心肌保护作用在大样本临床研究中得到验证.麻醉药的脑保护作用存在较大争议,也缺少简单、客观的疗效评价指标,还应开展大规模、多中心的临床研究.
痳醉藥的心腦保護作用一直廣受關註,但仍存在一些爭議.儘管多數臨床前研究髮現常用痳醉藥能減輕缺血/缺氧性心腦損傷,但臨床研究卻未得到確定性結論.綜述近年來關于痳醉藥心腦保護作用的臨床研究,尤其是隨機對照研究,結果錶明,多數常用的痳醉藥(吸入性痳醉藥異氟醚、七氟醚,靜脈痳醉藥丙泊酚、右美託咪定等)均錶現齣一定的心髒保護作用,其中氟烷類吸入性痳醉藥較靜脈痳醉藥效果更明顯,可顯著減輕心髒手術患者的心肌損傷.靜脈痳醉藥中,右美託咪定對心髒手術患者的心肌保護作用在大樣本臨床研究中得到驗證.痳醉藥的腦保護作用存在較大爭議,也缺少簡單、客觀的療效評價指標,還應開展大規模、多中心的臨床研究.
마취약적심뇌보호작용일직엄수관주,단잉존재일사쟁의.진관다수림상전연구발현상용마취약능감경결혈/결양성심뇌손상,단림상연구각미득도학정성결론.종술근년래관우마취약심뇌보호작용적림상연구,우기시수궤대조연구,결과표명,다수상용적마취약(흡입성마취약이불미、칠불미,정맥마취약병박분、우미탁미정등)균표현출일정적심장보호작용,기중불완류흡입성마취약교정맥마취약효과경명현,가현저감경심장수술환자적심기손상.정맥마취약중,우미탁미정대심장수술환자적심기보호작용재대양본림상연구중득도험증.마취약적뇌보호작용존재교대쟁의,야결소간단、객관적료효평개지표,환응개전대규모、다중심적림상연구.
Background The cardio-neuroprotective effect of anesthetics has been widely concerned but still controversial.Although strong preclinical data support that anesthetics could attenuate ischemic/hypoxic myocardial and cerebral injury,confirmative conclusions have not been demonstrated from clinical studies.We reviewed clinical trials in recent years(especially randomized controlled trials) on cardio-neuroprotection of commonly used anesthetic agents (volatile anesthetics:isoflurane,sevoflurane,intravenous anesthetics:propofol,dexmedetomidine).Among the mostly studied anesthetics that reveal the property of cardio-neuroprotection,ether-derived volatile anesthetics have shown more promising potentials than intravenous anesthetics,especially in cardiac surgeries.The cardio-neuroprotection of intravenous anesthetic dexmedetomidine was validated in heart surgery by randomized controlled trial with large sample.However,the neuroprotection of anesthetic agents is controversial,and there's lack of simple and objective evaluation indicators for it.Thus,large-scale,multicenter clinical trials are necessary in the future.